VOYA Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,732
| Closed | -$283K | – | 2967 |
|
|
2022
Q3 | $283K | Buy |
18,732
+812
| +5% | +$9.44K | ﹤0.01% | 2388 |
|
|
2022
Q2 | $134K | Buy |
17,920
+1,320
| +8% | +$9.3K | ﹤0.01% | 2546 |
|
|
2022
Q1 | $151K | Sell |
16,600
-191
| -1% | -$1.47K | ﹤0.01% | 2432 |
|
|
2021
Q4 | $118K | Sell |
16,791
-184,032
| -92% | -$1.93M | ﹤0.01% | 2641 |
|
|
2021
Q3 | $2.29M | Sell |
200,823
-10,341
| -5% | -$151K | ﹤0.01% | 1114 |
|
|
2021
Q2 | $3.38M | Sell |
211,164
-6,574
| -3% | -$113K | 0.01% | 996 |
|
|
2021
Q1 | $3.89M | Sell |
217,738
-455,530
| -68% | -$7.87M | 0.01% | 929 |
|
|
2020
Q4 | $9.1M | Buy |
673,268
+71,907
| +12% | +$869K | 0.02% | 610 |
|
|
2020
Q3 | $7.08M | Buy |
601,361
+12,040
| +2% | +$147K | 0.02% | 636 |
|
|
2020
Q2 | $8.7M | Sell |
589,321
-25,881
| -4% | -$383K | 0.02% | 578 |
|
|
2020
Q1 | $8.3M | Sell |
615,202
-3,824
| -0.6% | -$72.6K | 0.02% | 543 |
|
|
2019
Q4 | $15M | Sell |
619,026
-107,676
| -15% | -$2.23M | 0.03% | 476 |
|
|
2019
Q3 | $14M | Buy |
726,702
+266,296
| +58% | +$6.1M | 0.03% | 508 |
|
|
2019
Q2 | $13.6M | Buy |
460,406
+15,718
| +4% | +$606K | 0.03% | 517 |
|
|
2019
Q1 | $21.1M | Sell |
444,688
-54,264
| -11% | -$2.39M | 0.05% | 360 |
|
|
2018
Q4 | $18M | Buy |
498,952
+81,892
| +20% | +$3.84M | 0.04% | 386 |
|
|
2018
Q3 | $25.7M | Buy |
417,060
+31,367
| +8% | +$2.02M | 0.05% | 356 |
|
|
2018
Q2 | $26.1M | Sell |
385,693
-69,757
| -15% | -$3.9M | 0.06% | 364 |
|
|
2018
Q1 | $24.7M | Buy |
455,450
+57,522
| +14% | +$3.22M | 0.05% | 366 |
|
|
2017
Q4 | $23.8M | Sell |
397,928
-103,813
| -21% | -$6.3M | 0.05% | 373 |
|
|
2017
Q3 | $24.4M | Buy |
501,741
+148,965
| +42% | +$8.13M | 0.05% | 361 |
|
|
2017
Q2 | $18.5M | Buy |
352,776
+72,066
| +26% | +$3.36M | 0.04% | 419 |
|
|
2017
Q1 | $12.7M | Buy |
280,710
+1,752
| +0.6% | +$78.1K | 0.03% | 537 |
|
|
2016
Q4 | $10.6M | Buy |
278,958
+268,326
| +2,524% | +$10.1M | 0.03% | 561 |
|
|
2016
Q3 | $401 | Hold |
10,632
| – | – | ﹤0.01% | 1867 |
|
|
2016
Q2 | $187K | Buy |
+10,632
| New | +$172K | ﹤0.01% | 2295 |
|
|
2016
Q1 | – | Sell |
-179,548
| Closed | -$4.37M | – | 2533 |
|
|
2015
Q4 | $4.37M | Sell |
179,548
-104,425
| -37% | -$2.44M | 0.01% | 803 |
|
|
2015
Q3 | $5.04M | Sell |
283,973
-106,967
| -27% | -$1.94M | 0.01% | 760 |
|
|
2015
Q2 | $6.9M | Buy |
390,940
+198,093
| +103% | +$3.63M | 0.02% | 702 |
|
|
2015
Q1 | $6.04M | Buy |
+192,847
| New | +$5.59M | 0.01% | 743 |
|
VOYA Investment Management's AERI Position: Q4 2022 in Review
VOYA Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 18,732 shares — an estimated $283K sold.
VOYA Investment Management first reported a position in AERI in Q1 2015 and held it in 30 quarters. The position peaked at $26.1M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- VOYA Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- VOYA Investment Management sold 18,732 Aerie Pharmaceuticals shares in Q4 2022, an estimated $283K.
- VOYA Investment Management first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 30 quarters.
- VOYA Investment Management's Aerie Pharmaceuticals position peaked at $26.1M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on VOYA Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.